Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Reliance Life Sciences Pvt Ltd.

Home Clinical Trial Sponsors and OrganizationsReliance Life Sciences Pvt Ltd.

Reliance Life Sciences Pvt Ltd.

ACTIVE

Indiawww.rellife.comPrivate501–1,000 employeesEstablished: 2001-01-01

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

87

41 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

2001

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 3

44

50.6%

Phase 4

11

12.6%

Not Applicable

7

8.1%

Phase 2

7

8.1%

Phase 1

6

6.9%

Unknown

3

3.5%

Phase 2/3

2

2.3%

Trial Status Distribution

Active, not recruiting

32

36.8%

Completed

32

36.8%

Not yet recruiting

9

10.3%

Recruiting

10

11.5%

Unknown

4

4.6%

Clinical Trials

Trials sponsored by this organization (87)

To evaluate the safety effectiveness and Immune response of UstekiRel in 240 patients with Plaque Psoriasis, Psoriatic Arthritis, Ulcerative Colitis and Crohns Disease

Not yet recruiting

Jan 2026240 participants

To evaluate the safety and effectiveness of GolimuRel in patients with Rheumatoid Arthritis, Psoriatic Arthritis and Ulcerative Colitis. Golimurel will be administered in a total of 225 patients of these three indications and safety profile will be be evaluated as primary outcome in these patients.

Aug 2025225 participants

This is a comparative Phase II/ III study of bevacizumab with ranibizumab in an eye condition called Wet AMD. A total of 202 subjects are planned to be enrolled in this study, the primary outcome is to evaluate the efficacy of RLS bevacizumab in improving vision.

Jun 2025202 participants

A comparative clinical study to evaluate efficacy and safety of test drug in patients with Acute Ischemic stroke

Apr 2022225 participants

A study to evaluate the safety and efficacy of R-HSC-010 (stem cells) in patients with chronic kidney disease

Not yet recruiting

Jan 202212 participants

comparative clinical trial to evaluate safety and efficacy of test drug plus standard of care and standard of care alone in COVID 19 Acute Respiratory Distress Syndrome (ARDS) patients with non-invasive ventilation.

Not yet recruiting

Dec 202144 participants

The purpose of this research study is to evaluate the safety and effectiveness profile of the medicine named as EtanerRelTM in patients with different type of arthritis (joint pain)

Jul 2021230 participants

The purpose of this research study is to evaluate safety and efficacy of RanizuRelTM containing Ranibizumab for intra-vitreal injection, manufactured by Reliance Life Sciences, Pvt. Ltd. India in patients with neovascular (wet) age-related macular degeneration.

Jun 2021220 participants

Page 1 of 11

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials87
Approvals
News

Back to Organizations